Vice Chairman and Chief Executive Officer

Al Novak

Mr. Al Novak has over 25 years experience in the medical industry in the areas of finance, marketing, sales, business development and executive management. He served as president and CEO of Novoste Corporation, a NASD listed, cardiology company from 2002 until 2006. From 1998, Mr. Novak was a founder of Syntheon, LLC, a company engaged in the development of products for the GI and vascular markets. In 1996, he was employed as president and CEO of Biosense, Inc., an electrophysiology company acquired by Johnsons & Johnson in 1998. Mr. Novak joined Cordis Corporation, now a subsidiary of Johnson and Johnson, in 1984 and during his 13 years of service, he was employed in numerous executive management positions including chief financial officer. He serves as chairman of the board of ProRhythm, Inc., a privately-held, electrophysiology company, and on the board of directors of Cyberonics, Inc., a publicly-listed, neurostimulation company.